Beta-NAP Activators
Beta-NAP activators encompass a diverse array of chemical compounds that indirectly enhance the functional activity of Beta-NAP through modulation of various signaling pathways and cellular processes. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C, which is known to phosphorylate synaptic vesicle proteins including Beta-NAP, resulting in increased vesicle exocytosis. Likewise, Forskolin stimulates adenylyl cyclase, raising cAMP levels, which may lead to the activation of protein kinase A (PKA) and subsequent phosphorylation of Beta-NAP, augmenting synaptic function. Okadaic acid, by inhibiting protein phosphatases, maintains proteins in a phosphorylated state, potentially enhancing the activity of Beta-NAP. Brefeldin A disrupts the Golgi apparatus, increasing the cytosolic presence of Beta-NAP, indirectly promoting its synaptic activity. Vinpocetine, a phosphodiesterase inhibitor, and Kainic acid, a kainate receptor agonist, both elevate intracellular cAMP and calcium levels, respectively, thus indirectly enhancing Beta-NAP activity through PKA and calcium-dependent protein kinases.
Furthering the diversity of Beta-NAP activators, calcium channel blockers such as Verapamil and Nifedipine modulate intracellular calcium signaling, whichcould indirectly influence the activity of Beta-NAP by affecting calcium-dependent phosphorylation and signaling pathways. Nicotine and Amphetamine, which stimulate nicotinic acetylcholine receptors and induce monoamine release respectively, may indirectly increase Beta-NAP activity due to their effects on neurotransmitter release and synaptic activity. Ginkgolide B, by antagonizing platelet-activating factor (PAF) receptors, could modulate synaptic transmission in a way that enhances the dynamics of vesicle proteins such as Beta-NAP. Finally, Methylphenidate, known for its capacity to block the reuptake of monoamines like dopamine and norepinephrine, can indirectly lead to the increased activity of Beta-NAP by promoting neurotransmitter release, which is crucial for synaptic vesicle turnover and function. Collectively, these compounds, through their unique and specific effects on cellular signaling and synaptic processes, serve as indirect activators that elevate the functional activity of Beta-NAP without altering its expression levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a labdane diterpenoid known to activate adenylyl cyclase and increase cyclic AMP (cAMP) levels in various cell types. Elevated cAMP activates protein kinase A (PKA), which can then phosphorylate target proteins, including Beta-NAP. This phosphorylation potentially enhances Beta-NAP's functional activity by altering its conformation or interaction with other proteins. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a nonspecific inhibitor of phosphodiesterases. By preventing the breakdown of cAMP, it indirectly sustains the activation of PKA, which can lead to the phosphorylation and consequent activation of Beta-NAP. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which specifically breaks down cAMP. By inhibiting PDE4, rolipram raises cAMP levels, potentially enhancing PKA activity and leading to the phosphorylation of Beta-NAP, which may increase its functional activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) is known to activate G-protein coupled receptors that stimulate adenylyl cyclase, thereby increasing intracellular cAMP levels. The resulting PKA activation could lead to phosphorylation and activation of Beta-NAP. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors, which are coupled to adenylyl cyclase via Gs proteins. This interaction triggers an increase in cAMP and subsequent activation of PKA. PKA-mediated phosphorylation may enhance the activity of Beta-NAP. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine acting through its D1-like receptors can stimulate adenylyl cyclase, raising cAMP levels and activating PKA. PKA can then phosphorylate and potentially activate Beta-NAP. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to beta-adrenergic receptors, activating adenylyl cyclase and increasing cAMP levels. This leads to PKA activation, which may phosphorylate and activate Beta-NAP. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA then could phosphorylate and enhance the activity of Beta-NAP. | ||||||